跳至主要内容
临床试验/JPRN-UMIN000021849
JPRN-UMIN000021849未知未知

Phase II trial of apatinib in the treatment of metastatic penile cancer - Phase II trial of apatinib in the treatment of metastatic penile cancer

Fudan University Shanghai Cancer Center0 个研究点目标入组 26 人开始时间: 2016年4月10日最近更新:

试验速览

阶段
未知
入组人数
26

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18years-old 至 75years-old(—)
性别
Male

入选标准

  • 未提供

排除标准

  • 1) Usage of experimental drugs 2) History of serious drug allergy 3) uncontrolled hemorrhage 4) PS>1 5) heart failure 6) Double cancer 7) Coexisting severe medical conditions 8) Mental disease 9) Judged as inappropriate to participate this trial by investigators

研究者

相似试验

进行中(未招募)
1 期
Phase 2 trial of ponatinib in patients with metastatic and/or unresectable gastrointestinal stromal tumor (GIST) following failure or intolerance of prior therapy with imatinib (POETIG trial – POnatinib after rEsisTance to Imatinib in GIST)
EUCTR2015-002285-23-DEniversitaetsklinikum Essen81
已完成
2 期
Phase II trial of Lenvatinib in patients with metastatic or recurrent thymic carcinoma;REMORA trial (NCCH1508,REMORA trial)Thymic carcinoma
JPRN-UMIN000026777ational Cancer Center42
已完成
2 期
Phase II trial of Lenvatinib in patients with metastatic or recurrent thymic carcinomaThymic carcinoma
JPRN-jRCT2091220285oboru YamamotoDepartment of Experimental Therapeutics, National Cancer Center Hospital42
进行中(未招募)
1 期
Axitinib Treatment for Widespread Kidney Cancer Unsuitable for SurgeryMetastatic renal cell carcinomaMedDRA version: 19.0Level: LLTClassification code 10050076Term: Metastatic renal carcinomaSystem Organ Class: 100000004864
EUCTR2011-004562-16-GBInstitute of Cancer Research
进行中(未招募)
1 期
A trial to examine the effect of pazopanib on survival in patients with metastatic renal cell cancer who have already received and relapsed on, or did not tolerate sunitinib treatmentMetastatic or unresectable renal cell carcinomaMedDRA version: 21.1Level: PTClassification code 10067946Term: Renal cell carcinomaSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)
EUCTR2010-022770-13-IECancer Trials Ireland48